On 14 January 2025, the European Commission (“Commission”) published the findings of its first investigation under the EU’s International Procurement Instrument (“IPI”). Findings of the investigation…
Legislative developments
In terms of legislative developments, the year of 2024 was marked by the State Council’s issuance of the Regulation on Fair Competition Review. It supplemented the 2021…
The FSR and public procurement
The primary objective of the Foreign Subsidies Regulation (FSR) is to address the influence of foreign subsidies that may distort the integrity of the EU's internal…
Looking back on the year 2023, this note aims to give an update on the state of play in Chinese merger control. In particular, it looks at how merger control has evolved since China’s main antitrust…
Legislative developments
Following the amendment of the Anti-Monopoly Law (AML) in 2022, the State Administration for Market Regulation (SAMR) unveiled a series of departmental regulations in March…
On 29 May 2023, China’s antitrust authority – the State Administration for Market Regulation (“SAMR”) – published the decision against Zizhu Pharma on its webpage. The company was fined by SAMR’s…
Introduction
On 24 March 2023, China’s antitrust authority – the State Administration for Market Regulation (“SAMR”) – issued four regulations implementing the recently amended Anti-Monopoly Law (“…
On 12 January 2023, the new EU Foreign Subsidies Regulation (FSR) entered into force. The majority of the FSR will start to apply on 12 July 2023.
The FSR constitutes a new investigatory review tool…
The year of 2022 was marked by the first amendment of China’s Anti-Monopoly Law (AML) since its entry into force in 2008 and the gradual shift of the enforcement focus towards the objectives of the…
Yesterday, on 29 August 2022, clearance for the FAW/Refire joint venture transaction was announced on one of the websites of the Chinese antitrust authority – i.e., the State Administration for…
